Carbonyl stress in the pathogenesis of diabetic nephropathy

Internal Medicine

Volumn 38, Issue 4, 1999, Pages 309-314

  Suzuki, Daisuke ^a   Miyata, Toshio ^a  

^a TOKAI UNIVERSITY   (Japan)

Author keywords

Advanced glycation end products (AGEs); Carbonyl compounds; Glycoxidation; Oxidation

Indexed keywords

ADVANCED GLYCATION END PRODUCT; AMINO ACID;

CARBOHYDRATE METABOLISM; DIABETIC NEPHROPATHY; GLOMERULUS; HUMAN; LIPID METABOLISM; METABOLISM; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PATHOLOGY; REVIEW;

AMINO ACIDS; CARBOHYDRATE METABOLISM; DIABETIC NEPHROPATHIES; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; KIDNEY GLOMERULUS; LIPID METABOLISM; OXIDATION-REDUCTION; OXIDATIVE STRESS;

EID: 0033113321     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.38.309     Document Type: Review

References (60)

1. Brenner BM, Anderson S. Glomerular function in diabetes mellitus. Adv Nephrol Necker Hosp 19: 135-144, 1990.
2. Barnett PA, Gonzalez RG, Chylack LT Jr, Cheng HM. The effect of oxidation on sorbitol pathway kinetics. Diabetes 35: 426-432, 1986.
3. Greene DA, Lattimer SA, Sima AA. Sorbitol, phosphoinositides, and sodium-potassium-ATPase in the pathogenesis of diabetic complications. N Engl J Med 316: 599-606, 1987.
4. Inoguchi T, Battan R, Handler E, Sportsman JR, Heath W, King GL. Preferential elevation of protein kinase C isoform beta II and diacylglycerol levels in the aorta and heart of diabetic rats: differential reversibility to glycemic control by islet cell transplantation. Proc Natl Acad Sci USA 89: 11059-11063, 1992.
5. Lee TS, Saltsman KA, Ohashi H, King GL. Activation of protein kinase C by elevation of glucose concentration: proposal for a mechanism in the development of diabetic vascular complications. Proc Natl Acad Sci USA 86: 5141-5145, 1989 (published erratum appears in Proc Natl Acad Sci USA 88: 9907, 1991).
6. Yagame M, Eguchi K, Suzuki D, et al. Fibrinolysis in patients with diabetic nephropathy determined by plasmin-alpha2 plasmin inhibitor complexes in plasma. J Diabetic Complications 4: 175-178, 1990.
7. Krolewski AS, Doria A, Magre J, Warram JH, Housman D. Molecular genetic approaches to the identification of genes involved in the development of nephropathy in insulin-dependent diabetes mellitus. J Am Soc Nephrol 3 (Suppl): S9-17, 1992.
8. Suzuki D, Miyazaki M, Naka R, et al. In situ hybridization of interleukin 6 in diabetic nephropathy. Diabetes 44: 1233-1238, 1995.
9. Sakai H, Naka R, Suzuki D, et al. In situ hybridization analysis of TGF-beta in glomeruli from patients with IgA nephropathy. Contrib Nephrol 111: 107-115, 1995.
10. Abboud HE. Growth factors and diabetic nephropathy: an overview. Kidney Int Suppl 60: S3-S6, 1997.
11. Abboud HE. Growth factors in glomerulonephritis. Kidney Int 43: 252-267, 1993 (clinical conference).
12. Pfeiffer A, Schatz H. Diabetic microvascular complications and growth factors. Exp Clin Endocrinol Diabetes 103: 7-14, 1995.
13. Suzuki D, Miyazaki M, Jinde K, et al. In situ hybridization studies of matrix metalloproteinase-3, tissue inhibitor of metalloproteinase-1 and type IV collagen in diabetic nephropathy. Kidney Int 52: 111-119, 1997.
14. Suzuki D. Metalloproteinases in the Pathogenesis of Diabetic Nephropathy. Nephron 80: 125-133, 1998.
15. The Diabetes Control and Complications (DCCT) Research Group. Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetic Control and Complications Trial. Kidney Int 47: 1703-1720, 1995.
16. Bangstad HJ, Osterby R, Dahl-Jorgensen K, Berg KJ, Hartmann A, Hanssen KF. Improvement of blood glucose control in IDDM patients retards the progression of morphological changes in early diabetic nephropathy. Diabetologia 37: 483-490, 1994.
17. Dyer DG, Dunn JA, Thorpe SR, et al. Accumulation of Maillard reaction products in skin collagen in diabetes and aging. J Clin Invest 91: 2463-2469, 1993.
18. Brownlee M, Cerami A, Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 318: 1315-1321, 1988.
19. Suzuki D, Yagame M, Naka R, et al. Immunohistochemical staining of renal biopsy samples in patients with diabetic nephropathy in non-insulin dependent diabetes mellitus using monoclonal antibody to advanced glycation end products. Nephrology 1: 199-205, 1995.
20. Suzuki D, Yagame M, Jinde K, et al. Immunofluorescence staining of renal biopsy samples in patients with diabetic nephropathy in non-insulin-dependent diabetes mellitus using monoclonal antibody to reduced glycated lysine. J Diabetes Complications 10: 314-319, 1996.
21. e-carboxymethyllysine as a degradation product of fructoselysine in glycated protein. J Biol Chem 261: 4889-4894, 1986.
22. Sell DR, Monnier VM. Structure elucidation of a senescence cross-link from human extracellular matrix. Implication of pentoses in the aging process. J Biol Chem 264: 21597-21602, 1989.
23. Njoroge FG, Sayre LM, Monnier VM. Detection of D-glucose-derived pyrrole compounds during Maillard reaction under physiological conditions. Carbohydr Res 167: 211-220, 1987.
24. Sugiyama S, Miyata T, Ueda Y, et al. Plasma levels of pentosidine in diabetic patients: an advanced glycation end product. J Am Soc Nephrol 9: 1681-1688, 1998.
25. Sell DR, Lapolla A, Odetti P, Fogarty J, Monnier VM. Pentosidine formation in skin correlates with severity of complication in individuals with long-standing IDDM. Diabetes 41: 1286-1292, 1992.
26. McCance DR, Dyer DG, Dunn JA, et al. Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus. J Clin Invest 91: 2470-2478, 1993.
27. Horie K, Miyata T, Maeda K, et al. Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy. J Clin Invest 100: 2995-3004, 1997.
28. Beisswenger PJ, Moore LL, Brinck-Johnsen T, Curphey TJ. Increased collagen-linked pentosidine levels and advanced glycosylation end products in early diabetic nephropathy. J Clin Invest 92: 212-217, 1993.
29. Cohen MP, Ziyadeh FN. Amadori glucose adducts modulate mesangial cell growth and collagen gene expression. Kidney Int 45: 475-484, 1994.
30. Cohen MP, Surma ML, Wu VY. In vivo biosynthesis and turnover of glomerular basement membrane in diabetic rats. Am J Physiol 242: F385-F389, 1982.
31. Doi T, Vlassara H, Kirstein M, Yamada Y, Striker GE, Striker LJ. Receptor-specific increase in extracellular matrix production in mouse mesangial cells by advanced glycosylation end products is mediated via platelet-derived growth factor. Proc Natl Acad Sci USA 89: 2873-2877, 1992.
32. Yang CW, Vlassara H, Peten EP, He CJ, Striker GE, Striker LJ. Advanced glycation end products up-regulate gene expression found in diabetic glomerular disease. Proc Natl Acad Sci USA 91: 9436-9440, 1994.
33. Vlassara H, Brownlee M, Manogue KR, Dinarello CA, Pasagian A. Cachectin/TNF and IL-1 induced by glucose-modified proteins: role in normal tissue remodeling. Science 240: 1546-1548, 1998.
34. Miyata T, Inagi R, Iida Y, et al. Involvement of beta 2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis: Induction of human monocyte chemotaxis and macrophage secretion of tumor necrosis factor-alpha and interleukin-1. J Clin Invest 93: 521-528, 1994.
35. Miyata T, Iida Y, Ueda Y, et al. Monocyte/macrophage response to beta 2-microglobulin modified with advanced glycation end products. Kidney Int 49: 538-550, 1996.
36. Neeper M, Schmidt AM, Brett J, et al. Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J Biol Chem 267: 14998-15004, 1992.
37. Miyata T, Hori O, Zhang J, et al. The receptor for advanced glycation end products (RAGE) is a central mediator of the interaction of AGE-beta2microglobulin with human mononuclear phagocytes via an oxidant-sensitive pathway. Implications for the pathogenesis of dialysis-ralated amyloidosis. J Clin Invest 98: 1088-1094, 1996.
38. Skolnik EY, Yang Z, Makita Z, Radoff S, Kirstein M, Vlassara H. Human and rat mesangial cell receptors for glucose-modified proteins: potential role in kidney tissue remodelling and diabetic nephropathy. J Exp Med 174: 931-939, 1991.
39. Brett J, Schmidt AM, Yan SD, et al. Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues. Am J Pathol 143: 1699-1712, 1993.
40. Wells-Knecht KJ, Zyzak DV, Litchfield JE, Thorpe SR, Baynes JW. Mechanism of autoxidative glycosylation: identification of glyoxal and arabinose as intermediates in the autoxidative modification of proteins by glucose. Biochemistry 34: 3702-3709, 1995.
41. e(carboxymethyl) lysine, a product of the chemical modification of proteins by methylglyoxal, increases with age in human lens proteins. Biochem J 324: 565-570, 1997.
42. Glomb MA, Monnier VM. Mechanism of protein modification by glyoxal and glycolaldehyde, reactive intermediates of the Maillard reaction. J Biol Chem 270: 10017-10026, 1995.
43. e-(carboxymethyl) lysine by reaction between lysine and products of autoxidation of ascorbate. Biochemistry 29: 10964-10970, 1990.
44. Miyata T, Wada Y, Cai Z, et al. Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure. Kidney Int 51: 1170-1181, 1997.
45. e-(carboxymethyl) lysine, is a product of both lipid peroxidation and glycoxidation reactions. J Biol Chem 271: 9982-9986, 1996.
46. Esterbauer H, Schuer RJ, Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehyde. Free Radic Biol Med 11: 81-128, 1991.
47. Uchida K, Kanematsu M, Sakai K, et al. Protein-bound acrolein: potential markers for oxidative stress. Proc Natl Acad Sci USA 95: 4882-4887, 1998.
48. Anderson MM, Hazen SL, Hsu FF, Heinecke JW. Human neutrophils employ the myeloperoxidase-hydrogen peroxide-chloride system to convert hydroxy-amino acids into glycolaldehyde, 2-hydroxypropanal, and acrolein. A mechanism for the generation of highly reactive alpha-hydroxy and alpha, beta-unsaturated aldehydes by phagocytes at sites of inflammation. J Clin Invest 99: 424-432, 1997.
49. Baynes JW. Role of oxidative stress in development of complications in diabetes. Diabetes 40: 405-412, 1991.
50. Miyata T, van Ypersele de Strihou C, Kurokawa K, Baynes JW. Alterations in non-enzymatic biochemistry in uremia: origin and significance of "carbonyl stress" in long-term uremic complications. Kidney Int 55: 389-399, 1999.
51. Suzuki D, Miyata T, Saotome N, et al. Immunohistochemical evidence for an increased oxidative stress and carbonyl modification of proteins in diabetic glomerular lesion. J Am Soc Nephrol 10: 822-832, 1999.
52. Schmitz A, Gundersen HJ, Osterby R. Glomerular morphology by light microscopy in non-insulin-dependent diabetes mellitus. Lack of glomerular hypertrophy. Diabetes 37: 38-43, 1988.
53. Hayashi H, Karasawa R, Inn H, et al. An electron microscopic study of glomeruli in Japanese patients with non-insulin dependent diabetes mellitus. Kidney Int 41: 749-757, 1992.
54. Mauer SM, Steffes MW, Ellis EN, Sutherland DE, Brown DM, Goetz FC. Structural-functional relationships in diabetic nephropathy. J Clin Invest 74: 1143-1155, 1984.
55. Steffes MW, Osterby R, Chavers B, Mauer SM. Mesangial expansion as a central mechanism for loss of kidney function in diabetic patients. Diabetes 38: 1077-1081, 1989.
56. Steffes MW, Bilous RW, Sutherland DE, Mauer SM. Cell and matrix components of the glomerular mesangium in type I diabetes. Diabetes 41: 679-684, 1992.
57. Rhodes J. Covalent chemical events in immune induction: fundamental and therapeutic aspects. Immunol Today 9: 436-441, 1996.
58. Leonarduzzi G, Scavazza A, Biasi F, et al. The lipid peroxidation end product 4-hydroxy-2, 3-nonenal up-regulates transforming growth factor betal expression in the macrophage lineage: a link between oxidative injury and fibrosclerosis. FASEB J 11: 851-857, 1997.
59. Ahkand A, Kato M, Suzuki H, et al. Carbonyl stress modifies cell surface protein for activating protein-tyrosine kinase p60c-Src. J Cell Biochem 72: 1-7, 1999.
60. Yasuda Y, Miyata T, Ahkand A, et al. Carbonyl stress in diabetic glomerular lesions modifies mesangial cell surface protein for activating the intracellular protein tyrosine phosphorylation. J Am Soc Nephrol 9: 3296A (Abstract), 1998.